We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A phase 1 study of the CXCR4 antagonist plerixafor in combination with high-dose cytarabine and etoposide in children with relapsed or refractory acute leukemias or myelodysplastic syndrome: A Pediatric Oncology Experimental Therapeutics Investigators' Consortium study (POE 10-03).
- Authors
Cooper, Todd M.; Sison, Edward Allan Racela; Baker, Sharyn D.; Li, Lie; Ahmed, Amina; Trippett, Tanya; Gore, Lia; Macy, Margaret E.; Narendran, Aru; August, Keith; Absalon, Michael J.; Boklan, Jessica; Pollard, Jessica; Magoon, Daniel; Brown, Patrick A.
- Publication
Pediatric Blood & Cancer, 2017, Vol 64, Issue 8, pn/a
- ISSN
1545-5009
- Publication type
journal article
- DOI
10.1002/pbc.26414